Author

M. E. Ramey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 4 Research Focus:drug response / drug discovery· 3 Approach:statistical model· 3 Research Focus:benchmarking· 2 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. A. Bauman· 3 shared G. T. Robertson· 3 shared K. Rossmassler· 3 shared N. D. Walter· 3 shared S. Pauly· 3 shared C. Dide-Agossou· 2 shared M. I. Voskuil· 2 shared R. Al Mubarak· 2 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

A. A. Bauman

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Use of Multiple Pharmacodynamic Measures to Deconstruct the Nix-TB Regimen in a Short-Course Murine Model of Tuberculosis

M. A. Lyons, A. Obregon-Henao, M. E. Ramey, A. A. Bauman, S. Pauly, K. Rossmassler, J. Reid, B. Karger, N. D. Walter, G. T. Robertson

The paper evaluates the Nix-TB regimen in a murine TB model using pharmacodynamic markers to assess drug contributions and interactions.

bioRxiv · Nov 8, 2023Pharmacology & Toxicology

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses

N. D. Walter, J. P. Ernest, C. Dide-Agossou, A. A. Bauman, M. E. Ramey, K. Rossmassler, L. M. Massoudi, S. Pauly, R. Al Mubarak, M. I. Voskuil, F. Kaya, J. P. Sarathy, M. D. Zimmerman, V. Dartois, B. K. Podell, , G. T. Robertson

The paper shows that Mycobacterium tuberculosis in different lung microenvironments have distinct phenotypes and treatment responses in a mouse model.

bioRxiv · Feb 3, 2023 · PreprintMicrobiology

Combination of Mycobacterium tuberculosis RS ratio and CFU improves the ability of murine efficacy experiments to distinguish between drug treatments

C. Dide-Agossou, A. A. Bauman, M. E. Ramey, K. Rossmassler, R. Al Mubarak, S. Pauly, M. I. Voskuil, M. Garcia?Cremades, R. M. Savic, P. Nahid, C. M. Moore, R. Tasneen, E. Nuermburger, G. T. Robertson, N. D. Walter

bioRxiv · Dec 21, 2021Microbiology

Model-Based Meta-Analysis of Relapsing Mouse Model Studies from the Critical Path to Tuberculosis Drug Regimens Initiative Database

A. Berg, J. Clary, D. Hanna, E. Nuermberger, A. Lenaerts, N. Ammerman, M. E. Ramey, D. Hartley, D. Hermann

The paper performs a model-based meta-analysis of relapsing mouse model studies to compare TB drug regimen efficacy across multiple studies.

bioRxiv · Sep 13, 2021Pharmacology & Toxicology